(Date:11/9/2009)...USNewswire/ -- The Appignani Bioethics Center, a p...a panel discussion today at the National Press Clu...n biomedical sciences and climate change. The topi..., both of the Center for American Progress, who co...les. ,, A video of the event will be made avai...
(Date:11/9/2009)...ber 9 For more than 20 years,resea... development of a,Brain-Computer Interface (BCI). ... brain and a computer. Such a system enables compl...rol devices in their environment just by,mental ac...een supervised by,the researchers themselves to us...
(Date:11/9/2009)... top 10 pharmaceutical giants use Datafarm for pro...a. Datafarm’s announcement comes on the heel...ting where Health Canada stated that, effective im...D regulatory submissions for New Drug Submission (.... , Marlborough, MA (PRWE...
(Date:11/8/2009)...5, 2009 Complete Genomics, a third-generation hum...ication of a report in the journal Science descr...luding analysis of sequence data from three comple...hree genomes sequenced on the proof-of-principle g...overage to $1,726 for 45x coverage for the samples...
Breaking Biology Technology:Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3intendiX - Communication by Thoughts: First Patient-Ready System on the Market 2Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2...imon Pharmaceuticals, Inc., announced today the Co...daily topical diclofenac sodium patch Phase III pr...double-blind, placebo-controlled Phase III clinica...udies will assess the efficacy and safety of Cerim...treatment of acute pain caused by mild-to-moderate...
...25 Speid & Associates, an international regul...announced that it has entered into a partnership w...of new drug compounds using Genizon,s proprietary ...imate in which innovative pharmaceutical and biote... is spent on drug development, the Genizon and Spe...
... Cytopia Limited (ASX: CYT) has today circulated ...cals Limited (ASX: PGL) shareholders. The letter p...isitioned meeting scheduled for 27 March 2009 and ...oming general meeting on 11 March 2009. , , (Phot...Y75105 ) , , The letter and the sample proxy form...
Other Biology Technology:Cerimon Pharmaceuticals Initiates Phase III Clinical Studies to Evaluate Its Topical Diclofenac Sodium Patch for Mild-to-Moderate Pain 2Speid & Associates Partners With Genizon BioSciences to Reduce Attrition Rates of New Drug Compounds 2Cytopia Letter to Progen Shareholders 2Cytopia Letter to Progen Shareholders 3Cytopia Letter to Progen Shareholders 4Cytopia Letter to Progen Shareholders 5(Date:11/9/2009)..., For parents of children with cancer, the hopefu...ily improved for decades. Among the bad newstreatm... , Boys diagnosed with cancer who have reached... their fertility: before undergoing cancer treatme... in sperm banks. Younger boys, however, do not pro...
(Date:11/9/2009)..., The Springer journal Naturwissenschaften is p...les Darwin and Modern Biology" to commemorate Darw...150 years ago in November 1859. Guest editor and a... professor of plant physiology and evolutionary bi...articles in this special issue are available free ...
(Date:11/9/2009)... Delft, the Netherlands, November 09, 2009 / b3c...rch organization, and Seventh Wave, an American or...announce that the companies have signed a letter o...strointestinal models TIM. The letter of intent pr...obtain two TIM systems for commercialization in No...
Breaking Biology News(10 mins):For young boys with cancer, testicular tissue banking may be option to preserve fertility 2For young boys with cancer, testicular tissue banking may be option to preserve fertility 3TNO and Seventh Wave sign letter of intent on joint preclinical pharmaceutical outsourcing services 2Gen Probe Reports Financial Results for Second Quarter 2009 53283 1Gen Probe Reports Financial Results for Second Quarter 2009 53283 2Gen Probe Reports Financial Results for Second Quarter 2009 53283 3Gen Probe Reports Financial Results for Second Quarter 2009 53283 4Gen Probe Reports Financial Results for Second Quarter 2009 53283 5Gen Probe Reports Financial Results for Second Quarter 2009 53283 6Gen Probe Reports Financial Results for Second Quarter 2009 53283 7Gen Probe Reports Financial Results for Second Quarter 2009 53283 8Gen Probe Reports Financial Results for Second Quarter 2009 53283 9Gen Probe Reports Financial Results for Second Quarter 2009 53283 10Gen Probe Reports Financial Results for Second Quarter 2009 53283 11Gen Probe Reports Financial Results for Second Quarter 2009 53283 12Gen Probe Reports Financial Results for Second Quarter 2009 53283 13Gen Probe Reports Financial Results for Second Quarter 2009 53283 14Gen Probe Reports Financial Results for Second Quarter 2009 53283 15Gen Probe Reports Financial Results for Second Quarter 2009 53283 16Gen Probe Reports Financial Results for Second Quarter 2009 53283 17Gen Probe Reports Financial Results for Second Quarter 2009 53283 18Gen Probe Reports Financial Results for Second Quarter 2009 53283 19Gen Probe Reports Financial Results for Second Quarter 2009 53283 20Gen Probe Reports Financial Results for Second Quarter 2009 53283 21Gen Probe Reports Financial Results for Second Quarter 2009 53283 22WellPoint Announces Decision to Cover H1N1 Vaccine Administration 53281 1WellPoint Announces Decision to Cover H1N1 Vaccine Administration 53281 2Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan 53278 1Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan 53278 2Patents Issued Covering Stable Tablet Formulation and Once Daily Dosing Regimen for Kuvan 53278 3... benchmark for analytical performance , When yo...al,performance, the Varian 810-MS delivers.,,... collisional interface/extraction optics minimize,...e level,quantification. , Optimized sample in...
...ll-featured high-performance ICP-MS system designe...ed sampling interface, Omega II off-axis ion lens,...neous detector, the 7500a can handle the widest ra..., the 7500a now includes as standard Agilents uniq...
...tical to the DH-2000, except that it uses a deep-U...elength range and comes with a shutter (controlled...000 Deuterium Tungsten Halogen Light Source combin...en halogen light sources in a single optical path....
...LUMIstar OPTIMA is a fully automated microplate lu...possible range of applications based on luminescen...ctosidase, gene activities with luminescence subst...Luminescent Immunoassays Cell-based assays (cytot...
Biology Products: